Collegium Pharma (COLL) Posts Q1 Loss of $0.29/Sh

Collegium Pharma (NASDAQ: COLL) reported Q1 EPS of ($0.29), which may not compare to the analyst estimate of ($0.24). Revenue for the quarter came in at $74.5 million versus the consensus estimate of $70.82 million.

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Carnival shares drop despite earnings beat on weak guidance
• Goldman "broadly" raises estimates for LTL and truckload stocks